Rezo Therapeutics Rezo turns protein-protein interactions into drug targets, mapping disease networks with integrated biology and AI to design precision medicines.
Products & media
Sequence to Systems to Drugs (SSD) Platform
An AI-enabled drug-discovery platform that integrates proteomics, genetics, structural biology, chemistry, and bioinformatics to map disease networks and identify drug targets.
Team
Current Affiliates
1 person
Jobs
Funding
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.
Data current as of November 17, 2022
Leads
Participating Firms
Angels
Series A
$78M